FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2877541420> ?p ?o ?g. }

• W2877541420 abstract "As monotherapy, modified proline-rich antimicrobial peptides (PrAMPs) protect animals from experimental bacteremia in a dose-dependent manner. We evaluated the in vitro synergy of a modified PrAMP, A3-APO, a dimer, previously shown to inhibit the 70 kDa bacterial heat shock protein DnaK, with imipenem or colistin against two antibiotic-resistant pathogens; a carbapenemase-expressing Klebsiella pneumoniae strain K97/09 and Acinetobacter baumannii (ATCC BAA-1605). Combining antimicrobials resulted in synergy for PrAMP/colistin combination against both K. pneumoniae and A. baumannii (ΣFIC = 0.08 both) and additive activity for the A3-APO/imipenem combination against K. pneumoniae (ΣFIC = 0.53). Chex1-Arg20, (designated as ARV-1502 in preclinical development), the single chain PrAMP monomer of A3-APO, showed synergy with meropenem against a carbapenem-resistant uropathogenic Escherichia coli strain (ΣFIC = 0.38). In a murine bacteremia model using K97/09, A3-APO at 1 mg/kg demonstrated improved survival when co-administered with standard (10 mg/kg) or subtherapeutic (1 mg/kg) doses of colistin at 36 h (p < 0.05). Surprisingly, the survival benefit of A3-APO was augmented when the A3-APO dose was decreased by 50% to 0.5 mg/kg (p < 0.02) in conjunction with a subtherapeutic colistin dose (1 mg/kg). ARV-1502, as monotherapy demonstrated prolonged (>24 h) activity in a mouse Escherichia coli infection assay. Co-treatment with ARV-1502 and subtherapeutic doses of ceftazidime (150 mg/kg) was studied in a mouse model of melioidosis. ARV-1502 provided a 50% improvement in long-term (62 days) survival, but only at the lowest of 3 administered doses; survival advantage was demonstrated at 2.5 mg/kg but not at 5 or 10 mg/kg. The mortality benefit of combination therapies was not routinely accompanied by a parallel decline in blood or tissue bacterial counts in surviving animals, suggesting that the anti-infective activity of the host defense peptides (HDP) is broader than simply bacterial eradication. In fact, the hormetic effect observed in either animal models suggest that low dose HDP treatment may change the dominant mode of action in experimental bacteremia." @default.
• W2877541420 created "2018-07-19" @default.
• W2877541420 creator A5005596708 @default.
• W2877541420 creator A5020148591 @default.
• W2877541420 creator A5021089495 @default.
• W2877541420 creator A5051860064 @default.
• W2877541420 creator A5053751103 @default.
• W2877541420 creator A5057568298 @default.
• W2877541420 creator A5060722204 @default.
• W2877541420 creator A5064071267 @default.
• W2877541420 creator A5083730419 @default.
• W2877541420 date "2018-08-14" @default.
• W2877541420 modified "2023-10-18" @default.
• W2877541420 title "Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo" @default.
• W2877541420 cites W1659370522 @default.
• W2877541420 cites W1951178169 @default.
• W2877541420 cites W1965412761 @default.
• W2877541420 cites W1967758113 @default.
• W2877541420 cites W1968625612 @default.
• W2877541420 cites W1982656090 @default.
• W2877541420 cites W1994661085 @default.
• W2877541420 cites W1997333646 @default.
• W2877541420 cites W2005657074 @default.
• W2877541420 cites W2012044884 @default.
• W2877541420 cites W2021755523 @default.
• W2877541420 cites W2025410794 @default.
• W2877541420 cites W2026881549 @default.
• W2877541420 cites W2030688500 @default.
• W2877541420 cites W2032095183 @default.
• W2877541420 cites W2041132225 @default.
• W2877541420 cites W2044458410 @default.
• W2877541420 cites W2054337320 @default.
• W2877541420 cites W2054602599 @default.
• W2877541420 cites W2054607729 @default.
• W2877541420 cites W2057874299 @default.
• W2877541420 cites W2077911155 @default.
• W2877541420 cites W2080086899 @default.
• W2877541420 cites W2095231417 @default.
• W2877541420 cites W2098783085 @default.
• W2877541420 cites W2100324347 @default.
• W2877541420 cites W2102532232 @default.
• W2877541420 cites W2125897199 @default.
• W2877541420 cites W2127343455 @default.
• W2877541420 cites W2132632272 @default.
• W2877541420 cites W2147684469 @default.
• W2877541420 cites W2151530686 @default.
• W2877541420 cites W2152842396 @default.
• W2877541420 cites W2155427012 @default.
• W2877541420 cites W2158988420 @default.
• W2877541420 cites W2161807567 @default.
• W2877541420 cites W2163015800 @default.
• W2877541420 cites W2290257677 @default.
• W2877541420 cites W2307306806 @default.
• W2877541420 cites W2515984871 @default.
• W2877541420 cites W2527620221 @default.
• W2877541420 cites W2731234701 @default.
• W2877541420 cites W2775239537 @default.
• W2877541420 cites W2777532854 @default.
• W2877541420 doi "https://doi.org/10.3389/fchem.2018.00309" @default.
• W2877541420 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6102830" @default.
• W2877541420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30155456" @default.
• W2877541420 hasPublicationYear "2018" @default.
• W2877541420 type Work @default.
• W2877541420 sameAs 2877541420 @default.
• W2877541420 citedByCount "27" @default.
• W2877541420 countsByYear W28775414202018 @default.
• W2877541420 countsByYear W28775414202019 @default.
• W2877541420 countsByYear W28775414202020 @default.
• W2877541420 countsByYear W28775414202021 @default.
• W2877541420 countsByYear W28775414202022 @default.
• W2877541420 countsByYear W28775414202023 @default.
• W2877541420 crossrefType "journal-article" @default.
• W2877541420 hasAuthorship W2877541420A5005596708 @default.
• W2877541420 hasAuthorship W2877541420A5020148591 @default.
• W2877541420 hasAuthorship W2877541420A5021089495 @default.
• W2877541420 hasAuthorship W2877541420A5051860064 @default.
• W2877541420 hasAuthorship W2877541420A5053751103 @default.
• W2877541420 hasAuthorship W2877541420A5057568298 @default.
• W2877541420 hasAuthorship W2877541420A5060722204 @default.
• W2877541420 hasAuthorship W2877541420A5064071267 @default.
• W2877541420 hasAuthorship W2877541420A5083730419 @default.
• W2877541420 hasBestOaLocation W28775414201 @default.
• W2877541420 hasConcept C104317684 @default.
• W2877541420 hasConcept C150903083 @default.
• W2877541420 hasConcept C185592680 @default.
• W2877541420 hasConcept C207001950 @default.
• W2877541420 hasConcept C2776315533 @default.
• W2877541420 hasConcept C2776685102 @default.
• W2877541420 hasConcept C2777058267 @default.
• W2877541420 hasConcept C2777637488 @default.
• W2877541420 hasConcept C2779259085 @default.
• W2877541420 hasConcept C2779375183 @default.
• W2877541420 hasConcept C2779631663 @default.
• W2877541420 hasConcept C4937899 @default.
• W2877541420 hasConcept C501593827 @default.
• W2877541420 hasConcept C523546767 @default.
• W2877541420 hasConcept C54355233 @default.
• W2877541420 hasConcept C547475151 @default.
• W2877541420 hasConcept C55493867 @default.
• W2877541420 hasConcept C71924100 @default.

• next